Clinical Screening for Major Depression Disorder treatment study proved a good opportunity for pharmacies in the St. Louis, MO metro area to boost patient engagement and pharmacy revenue. Tyler Taylor CPESN Missouri regional facilitator, said the RxE2 program paid pharmacies for all steps regardless of outcome, saying that's "... very helpful in a world where we don't get paid for our work very often."

Expansion of a Medicaid MCO program allows CPESN® Pennsylvania pharmacist to add diabetes disease management to services they provide to Medicaid patients. Additionally, they will now be paid for Social Determinants of Health screenings and referrals.

Laura Rhodes, CPESN USA Regional PPP Lead, describes how quality performance by CPESN® Florida pharmacies in a 2022 Medicaid adherence program has led to renewal in that state with opportunities for nearly three times as many pharmacies, and expansion to Texas where almost 90 CPESN pharmacies will be able to participate. The two networks trained together last week, preparing for the renewal and rollout in Texas.

Helping Medicaid patients diagnosed with diabetes or hypertension control their blood pressure or lower their HbA1c is the focus goal of a broad statewide managed Medicaid program available to the nearly 200 CPESN® Pennsylvania pharmacies across the state. Early patient outcomes include significantly lowered HbA1C levels and impactful referrals to other community providers based on social determinants of health surveys.

Brianna Chesser, a pharmacist with Best Value Ridglea Pharmacy in Fort Worth, shares examples of how CPESN® Texas pharmacies are helping to improve the health of diabetes and CVD patients enrolled in a managed Medicaid program.

Sarah Covert, a pharmacist with McCoy-Tygart Drug in Sheridan, AR describes how her team works with rural patients enrolled in a Medicaid MCO plan. Understanding and addressing health inequities is part of her efforts to improve medication adherence.

CPESN® Hawaii pharmacies reached out to Medicare programs with medication adherence gaps for treating diabetes, hypertension, and other chronic illnesses. In addition to meeting year-end goals for the health plan, the pharmacies coached patients to support their longer term health outcomes.

Rebecca Wagers, CPESN® NET Managing Network Facilitator, says the Emergent ACO Special Purpose Partnership has expanded to seven states and that CPESN pharmacies have submiitted more than 50,000 eCare plans. And that's just the start.

Eric Hughes, CPESN® Arkansas Managing Network Facilitator, describes one of three new RxE2 clinical trial recruitment recruitment opportunities for 2023. In this multi-state recruitment, pharamcies in several networks review prescribing records to identify patients with treatment-resistent depression. Some patients with a specific gene marker may participate in an investigational drug study. It's a payable opportunity for patients, and creates network revenue as well.

Community pharmacies educating patients - especially in underserved communities - about health conditions and access to clinical trials is the focus of a partnership between CPESN® USA and Inside Edge Consulting Group.